The MedicX Fund Limited Publication of Circular - Scrip Dividend Scheme (9269O)
May 22 2018 - 10:24AM
UK Regulatory
TIDMMXF
RNS Number : 9269O
The MedicX Fund Limited
22 May 2018
For immediate release
22 May 2018
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Publication of Circular to Shareholders - Scrip Dividend
Scheme
On 1 May 2018, the Board of MedicX Fund Limited announced:
(a) that a quarterly dividend of 1.51p per Ordinary Share had
been approved in respect of the period 1 January 2018 to 31 March
2018, payable on 29 June 2018 to Shareholders on the register as at
close of business on 18 May 2018 (the "June 2018 Dividend"); (b)
the quarterly dividend will comprise 50% (0.755p) Property Income
Distribution ("PID") and 50% ordinary dividend (0.755p); and (c)
that Shareholders would be offered the opportunity to take up new
Ordinary Shares ("Scrip Shares") instead of cash in respect of that
dividend, subject to certain terms and conditions, by participating
in the Scrip Dividend Scheme (the "Scheme").
Accordingly, the Board is now pleased to offer qualifying
Shareholders the opportunity to receive the June 2018 Dividend in
Scrip Shares (the "Scrip Dividend Alternative") instead of in
cash.
The Company posted today, to Shareholders new to the Company
since on or after 17 February 2018, a letter from the Chairman and
a copy of the Scheme Document setting out the detailed terms and
conditions of the Scheme (together the "Circular"). This
correspondence was also send in hard copy form to those
Shareholders who have elected to receive correspondence by post and
a link to these documents was e-mailed to those Shareholders who
have elected and notified the Company that they wish to receive
electronic communications. Other Shareholders who have deemed to
have consented to electronic communications via the Company's
website can view or download the latest Circular which can be found
on the following link:
http://www.medicxfund.com/investors/scrip-dividend-scheme.
Certificated Shareholders who wish to elect for the Scrip
Dividend Alternative can do so online at
https://www.signalshares.com or a Mandate Form can be obtained by
contacting the Company's registrar, Link Asset Services on 0371 664
0321*. Uncertificated Shareholders can make an election via the
CREST system.
Scrip dividends are attractive to many shareholders because they
enable them to increase their holding in the Company in a simple
manner without incurring any dealing costs or stamp duty. At the
same time, the Company will retain more cash in its business which
would otherwise be paid as a dividend. Shareholders are encouraged
to review the details of the Scheme and the associated documents,
which may be found on the Company website as detailed above, or
alternatively may be viewed through the National Storage Mechanism
(www.morningstar.co.uk/uk/nsm).
The price at which the June 2018 Dividend will be converted into
Scrip Shares (the "Scrip Calculation Price") will be announced to
the London Stock Exchange by 24 May 2018. This announcement
(together with details of the Scheme) will also appear on the
Company's website www.medicxfund.com. The Scrip Calculation Price
is the average of the closing middle market quotations of an
Ordinary Share, derived from the London Stock Exchange Daily
Official List, for the five consecutive business days commencing on
the Ex-dividend Date.
If qualifying Shareholders wish to elect to participate in the
Scrip Dividend Alternative in relation to the June 2018 Dividend
their election, Mandate Form (or relevant CREST election) must be
received by Link Asset Services by no later than 5.00 p.m. on 8
June 2018 (the "Delivery Deadline"). Shareholders should refer to
the Circular for the full terms and conditions of the Scheme and
the election procedure for certificated and uncertificated
Shareholders. Mandate Forms remain valid for all Relevant Dividends
where a Scrip Dividend Alternative is offered, until cancelled.
A copy of the Circular has been submitted to the Financial
Conduct Authority and is available for inspection through the
National Storage Mechanism (www.morningstar.co.uk/uk/nsm).
Calls are charged at the standard geographic rate and will vary
by provider. Calls outside the United Kingdom will be charged at
the applicable international rate. The helpline is open between
9.00 am - 5.30 pm, Monday to Friday excluding public holidays in
England and Wales. Please note that Link Asset Services cannot
provide any financial, legal or tax advice and calls may be
recorded and monitored for security and training purposes.
End
For further information please contact:
Octopus Healthcare Adviser Ltd +44 (0) 345 0404 5555
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Henry Wilson
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the
"Company", or together with its subsidiaries, the "Group") is the
specialist primary care infrastructure investor in modern,
purpose-built primary healthcare properties in the United Kingdom
and Ireland, listed on the London Stock Exchange, with a portfolio
comprising 154 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1.4 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP7.7 billion of funds for more than 50,000 retail and
institutional investors as well as supplying energy to more than
180,000 customers
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
CIRBUGDUBDDBGID
(END) Dow Jones Newswires
May 22, 2018 11:24 ET (15:24 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024